Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Ranibizumab

Brand: 
NICE TA: 155
Indication: Age-related macular degeneration (NICE TA155)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

LMMG is adopting the local decision made prior to April 2013

Recommendation

LMMG recommendation: Red
Click here to find the definitions for the colour classifications

Reason for decision:  Specialist medicine

Supporting documents:

NICE TA155 - Ranibizumab and pegaptanib for the treatment of age-related macular degeneration

 

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red